维普中文期刊产品整合服务
53篇 您的检索式:作者名="Ludovini"
    题名 作者 年代 出处 被引量
1MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies显示文摘Federico Cappuzzo Andrea Sacconi Lorenza Landi Vienna Ludovini Francesca Biagioni Armida D’Incecco Alessandra Capodanno Jessica Salvini Enrichetta Corgna Samanta Cupini Cecilia Barbara Gabriella Fontanini Lucio Crinò Giovanni Blandino 2013Clinical Colorectal Cancer2013,,:3
2Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival 显示文摘Ludovini V Gori S Colozza M 2008Ann Oncol2008,19,5:1
3Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology 显示文摘Ludovini V Pistola L Gregorc V 2008J Thorac Oncol2008,3,4:1
4Increased levels of circulat- ing DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjogren' s syndrome显示文摘E Bartoloni V Ludovini A Alunnol 2011Lupus2011,20,9:1
5Plasma DNA,microsatellite alterations,and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients:a study of the perugia multidisciplinary team for thoracic oncology显示文摘Ludovini V Pistola L Gregorc V 2008J Thorac Oncol2008,3,4:1
6Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages Ⅰ and Ⅱ breast cancer patients 显示文摘Ludovini V Sidoni A Pistola L 2003Breast Cancer Res Treat2003,81,2:1
7High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients显示文摘Ludovini V Bellezza G Pistola L 2009Ann Oncol2009,20,:1
8lncreased levels of circu- lating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjogren's syndrome显示文摘Bartoloni E Ludovini V Alunnol A 2011Lu- pus2011,20,9:1
9Increased levels of circulating DNA in patients with systemic autoimmune diseases:apossible marker of disease activity in Sjgren′s syndrome显示文摘Bartoloni E Ludovini V Alunno A 2011Lupus2011,20,9:1
10Long-term response to gefitinib and crizotinib in lung adenocarcinoma harboring both ep- idermal growth factor receptor mutation and EMIA-ALK fusion gene显示文摘Chiari R Duranti S Ludovini V 2014J Clin Oncol2014,32,9:1
11VEGF and S100 beta serum levels in advanced non-small cell lung cancer (NSCLC)patients with and without brain metastases(BM)at diagnosis显示文摘 V Ludovini L Pistola 2005Eur J Cancer Supplements2005,3,2:1
12Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer显示文摘Ludovini V Gregorc V Pistola L 2004Lung Cancer2004,46,:1
13Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages Ⅰ and Ⅱ breast cancer patients显示文摘Ludovini V Sidoni A Pistols L 2003Breast Cancer Res Treat2003,81,2:1
14Evaluation of serum HER2 extracellular domain in early breast cancer pa- tients: correlation with clinicopathological parameters and survival显示文摘Ludovini V Gori S Colozza M 2008Ann Oncol2008,19,5:1
156088 POSTER KRAS and EGFR MicroRNAs regulation and cetuximab/panitumumab sensi- tivity in metastatic colorectal cancer patients 显示文摘Landi L Biagioni F Ludovini V 2011Eur J Cancer2011,47,1:1
16Phosphoinositide-3 Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhihitors in Patients with Advanced Non-small Cell Lung Cancer显示文摘Ludovini V Bianconi F Pistola L 0,,:1
17Evaluation of serum HER2 extracellular domain in early breast cancer patients: cor- relation with clinicopathological parameters and survival 显示文摘Ludovini V Gori S Colozza M 2008Ann Oneol2008,19,5:1
18Influence of serum vascular endothelial growth factor (VEGF) and haemoglobin (Hb) levels on survival of non-small cell lung cancer patients (NSCLC)显示文摘Gregorc V Ludovini V Pistola L 2002Ann Oncol2002,13,3:1
19Serum level changes of matrix metalloproteinases 2 and 9 ,vascular en- dothelial growth factor and epidermal growth factor re- ceptor during platinum-based chemotherapy in advancednon-small cell lung cancer patients显示文摘Mihaylova Zh Ludovini V Gregorg V 2007J BUON2007,12,1:1
20Vascular endothelial growth factor,p53,Rb,Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer显示文摘 Gregorc V Pistola L 2004Lung Cancer2004,46,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费